Search by Drug Name or NDC
NDC 63868-0339-12 QC Anti Diarrheal 262 mg/15mL Details
QC Anti Diarrheal 262 mg/15mL
QC Anti Diarrheal is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION). The primary component is BISMUTH SUBSALICYLATE.
MedlinePlus Drug Summary
Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
Related Packages: 63868-0339-12Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bismuth Subsalicylate
Product Information
NDC | 63868-0339 |
---|---|
Product ID | 63868-339_9f3723f1-cec3-4fc8-a8fc-10fc29b7f2a5 |
Associated GPIs | 47300010001805 |
GCN Sequence Number | 002858 |
GCN Sequence Number Description | bismuth subsalicylate ORAL SUSP 262MG/15ML ORAL |
HIC3 | D6D |
HIC3 Description | ANTIDIARRHEALS |
GCN | 26970 |
HICL Sequence Number | 001246 |
HICL Sequence Number Description | BISMUTH SUBSALICYLATE |
Brand/Generic | Generic |
Proprietary Name | QC Anti Diarrheal |
Proprietary Name Suffix | Vanilla Regular Flavor |
Non-Proprietary Name | Bismuth subsalicylate |
Product Type | HUMAN OTC DRUG |
Dosage Form | SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 262 |
Active Ingredient Units | mg/15mL |
Substance Name | BISMUTH SUBSALICYLATE |
Labeler Name | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M008 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63868-0339-12 (63868033912)
NDC Package Code | 63868-339-12 |
---|---|
Billing NDC | 63868033912 |
Package | 355 mL in 1 BOTTLE, PLASTIC (63868-339-12) |
Marketing Start Date | 2019-04-16 |
NDC Exclude Flag | N |
Pricing Information | N/A |